Dosing patterns and clinical parameters in patients treated with sacubitril/valsartan in patients with heart failure

Trial Profile

Dosing patterns and clinical parameters in patients treated with sacubitril/valsartan in patients with heart failure

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Apr 2018

At a glance

  • Drugs Sacubitril/valsartan (Primary)
  • Indications Heart failure
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Apr 2018 Results comparing dosing patterns and changes in clinical parameters after Sacubitril/valsartan in patients from this trial and PARADIGM-HF, published in the Postgraduate Medicine
    • 28 Nov 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top